1. Home
  2. BIVI vs AMST Comparison

BIVI vs AMST Comparison

Compare BIVI & AMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIVI
  • AMST
  • Stock Information
  • Founded
  • BIVI 2013
  • AMST 2017
  • Country
  • BIVI United States
  • AMST United States
  • Employees
  • BIVI N/A
  • AMST N/A
  • Industry
  • BIVI Biotechnology: Pharmaceutical Preparations
  • AMST Computer Software: Prepackaged Software
  • Sector
  • BIVI Health Care
  • AMST Technology
  • Exchange
  • BIVI Nasdaq
  • AMST Nasdaq
  • Market Cap
  • BIVI 11.9M
  • AMST 13.3M
  • IPO Year
  • BIVI N/A
  • AMST 2020
  • Fundamental
  • Price
  • BIVI $1.82
  • AMST $3.53
  • Analyst Decision
  • BIVI
  • AMST
  • Analyst Count
  • BIVI 0
  • AMST 0
  • Target Price
  • BIVI N/A
  • AMST N/A
  • AVG Volume (30 Days)
  • BIVI 323.5K
  • AMST 2.1M
  • Earning Date
  • BIVI 11-12-2025
  • AMST 11-13-2025
  • Dividend Yield
  • BIVI N/A
  • AMST N/A
  • EPS Growth
  • BIVI N/A
  • AMST N/A
  • EPS
  • BIVI N/A
  • AMST N/A
  • Revenue
  • BIVI N/A
  • AMST $82,544.00
  • Revenue This Year
  • BIVI N/A
  • AMST N/A
  • Revenue Next Year
  • BIVI N/A
  • AMST N/A
  • P/E Ratio
  • BIVI N/A
  • AMST N/A
  • Revenue Growth
  • BIVI N/A
  • AMST N/A
  • 52 Week Low
  • BIVI $1.42
  • AMST $2.00
  • 52 Week High
  • BIVI $75.00
  • AMST $6.27
  • Technical
  • Relative Strength Index (RSI)
  • BIVI 33.82
  • AMST 63.73
  • Support Level
  • BIVI $1.54
  • AMST $3.14
  • Resistance Level
  • BIVI $2.03
  • AMST $4.78
  • Average True Range (ATR)
  • BIVI 0.15
  • AMST 0.27
  • MACD
  • BIVI 0.23
  • AMST 0.11
  • Stochastic Oscillator
  • BIVI 65.57
  • AMST 42.01

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

About AMST Amesite Inc.

Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.

Share on Social Networks: